LEXICON
No.149 July 31, 2015

Price Maintenance Premium
新薬創出加算

The “price maintenance premium (PMP)” (新薬創出加算; shinyaku soshutsu kasan ), also called “innovation premium,” was introduced on a pilot basis in April 2010 under the FY2010 NHI pricing reform. The PMP is designed to effectively maintain the NHI prices of...

To read the full story

LEXICON

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…